Related Experiment Video

Updated: Jul 17, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

[Progress in the study of polycythemia vera in children]

Liang-Jia Hu1, Wen-Yu Yang1

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin 300020, China.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|July 15, 2026
PubMed

Insights

Pediatric polycythemia vera, a rare blood cancer, needs specific treatments. This review covers causes, symptoms, diagnosis, and therapies for children with this condition.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Molecular Biology

Background:

  • Pediatric polycythemia vera is a rare myeloproliferative neoplasm.
  • Adult polycythemia vera research is established, but pediatric protocols are lacking.
  • Children's unique physiology necessitates distinct management strategies.

Purpose of the Study:

  • To systematically review the etiology, clinical manifestations, diagnostic methods, and therapeutic advances of pediatric polycythemia vera.
  • To provide evidence supporting clinical decision-making and basic research in pediatric polycythemia vera.

Main Methods:

  • Systematic literature review.
  • Analysis of etiological factors.
  • Review of clinical presentations.
  • Evaluation of diagnostic techniques.
  • Assessment of therapeutic interventions.

Main Results:

  • Etiology and clinical manifestations of pediatric polycythemia vera are diverse.
  • Diagnostic criteria require careful consideration of pediatric-specific factors.
  • Therapeutic landscape is evolving, with a need for tailored approaches.

Conclusions:

  • Standardized diagnostic and therapeutic protocols for pediatric polycythemia vera are crucial.
  • Further research is needed to optimize management strategies for children.
  • Evidence-based guidelines are essential for improving outcomes in pediatric polycythemia vera.

Keywords:
ChildMyeloproliferative neoplasmPolycythemia veraThrombosis

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...